Pressrelease – Lund, June 25th, 2026 – Hamlet BioPharma secures drug manufacturing at Phase III quality and release of Alpha1H for distribution to clinical trial sites June 25, 2026
Pressrelease – Lund, June 23rd, 2026 – Hamlet BioPharma’s monthly digital investors’ meeting on June 30th June 23, 2026
Press release – Lund, June 22th, 2026 – Clinical trial expansion in the US, in collaboration with the University of Iowa, to treat high-risk, resistant, non-muscle-invasive bladder cancer (NMIBC) June 22, 2026
Press release – Lund, June 17th, 2026 – Pre-initiation visit in Prague, for the Phase III trial of Alpha1H in bladder cancer June 17, 2026
